| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |